EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Osteoarthritis and cardiometabolic diseases: shared mechanisms, modifiable risk factors, and integrated management strategies

Patricia Yl Chan, Shiwen Yuan, David J Hunter iD

Expert Review of Clinical Pharmacology · 2026

DOI: 10.1080/17512433.2026.2649611 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2026. Verfasst von Patricia Yl Chan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Northen Clinical School, Kolling Institute of Medical Research, St Leonards, NSW, Australia. Hauptthemen laut MEDLINE: Cardiometabolic Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Metabolic Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Osteoarthritis (OA) and cardiometabolic diseases (CMD), including metabolic syndrome, type 2 diabetes, and cardiovascular disease, are common chronic disorders sharing risk factors, mechanisms, and societal burdens. Obesity, insulin resistance, dyslipidaemia, hypertension, and inflammation link joint damage with vascular and metabolic issues. Factors such as advanced glycation end-products, adipokines, and cytokines including interleukin-6 and C-reactive protein drive systemic and local inflammation, accelerating joint deterioration and cardiovascular problems. AREAS COVERED: We searched MEDLINE, PubMed, Embase, Cochrane, Scopus, CIAP, and Google Scholar from January 2011 to October 2025. Evidence supports a bidirectional relationship where OA worsens cardiometabolic risk via inactivity, and CMD accelerates OA through vascular and metabolic stress. Without disease-modifying drugs, lifestyle interventions like weight management and physical activity are key. Multidisciplinary care targeting shared modifiable risk factors can improve outcomes. EXPERT OPINION: Future research should investigate shared molecular pathways using approaches like multi-omics, validate early-detection biomarkers, and assess multimodal interventions that link musculoskeletal and metabolic health. A patient-centered approach to OA and CMD offers the best chance to reduce disability and disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiometabolic Risk FactorsCardiovascular DiseasesDiabetes Mellitus, Type 2Metabolic SyndromeOsteoarthritisHumansBiomarkersBody WeightLife StyleMetabolic Networks and PathwaysExercise TherapyObesity

Stichwörter der Autor:innen

GLP-1 receptor agonistsOsteoarthritiscardiometabolic diseaseinflammationintegrated carelifestyle interventionmetabolic syndromeobesity

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Northen Clinical School, Kolling Institute of Medical Research, St Leonards, NSW, Australia.
  • Department of Rheumatology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, China.
  • The Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Rheumatology Department, Royal North Shore Hospital, St Leonards, NSW, Australia.

ORCID-Profile: David J Hunter

Zitieren

APA

Chan, P. Y., Yuan, S., & Hunter, D. J. (2026). Osteoarthritis and cardiometabolic diseases: shared mechanisms, modifiable risk factors, and integrated management strategies. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2026.2649611

Vancouver

Chan PY, Yuan S, Hunter DJ. Osteoarthritis and cardiometabolic diseases: shared mechanisms, modifiable risk factors, and integrated management strategies. Expert Review of Clinical Pharmacology. 2026. doi:10.1080/17512433.2026.2649611

BibTeX
@article{Chan2026,
  author = {Chan, Patricia Yl and Yuan, Shiwen and Hunter, David J},
  title = {Osteoarthritis and cardiometabolic diseases: shared mechanisms, modifiable risk factors, and integrated management strategies},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2026},
  doi = {10.1080/17512433.2026.2649611}
}
Kostenlos starten →